Finished
Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis
NCT04000373 · The Cleveland Clinic · Updated 27 June 2022
- What is being tested
- Ekso GT™ exoskeleton
- For
- Multiple Sclerosis; Gait Disorders, Neurologic
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 5 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 23 July 2019, ends 9 Jan 2020. Registered 27 June 2019.
- Results
- Posted on the registry on 7 April 2020.
In the researchers' words
The investigator plans to test the use of the Ekso Bionics® Gait Training (Ekso GT™) exoskeleton for gait training in MS patients. The device will solely be used in the clinic under direct supervision from a physical therapist. This is a small PI-initiated uncontrolled pilot study to gather safety and feasibility data on the exoskeleton in individuals with MS and walking impairment.
Sites
- Cleveland Clinic Neurological Institute Mellen CenterCleveland, Ohio, United States